United States - Map
BIOLASE, Inc., a biomedical company, develops, manufactures, and markets lasers in dentistry and medicine in the Unites States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications. The company also markets and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional printers, as well as provides precision intuitive diagnosis and treatment planning solutions. In addition, it offers medical systems comprising Diolase 10 Diode Laser for therapeutic applications consisting of temporary pain relief; topical heating for the purpose of temporarily relieving minor muscle and joint pain and stiffness, minor arthritis pain, muscle spasm, minor sprains and strains, and minor muscular back pain; temporarily increasing local blood circulation; and temporarily relaxing muscles. Further, the company manufactures and sells disposable products and accessories for laser systems, as well as markets flexible fibers and hand pieces. BIOLASE, Inc. has a strategic agreement with Valam, Inc. to develop, market, and sell office-based laser systems to otolaryngologists. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.
|BIOLASE, Inc.’s ISS Governance QuickScore as of Apr 1, 2014 is 9. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 5; Compensation: 7.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Federico Pignatelli ,
Exec. Chairman, Chief Exec. Officer and Member of Secondary Stock Option Committee
|Dr. Alexander K. Arrow M.D., C.F.A.,
Pres, Chief Operating Officer, Chairman of Compensation Committee, Member of Audit Committee, Member of Nominating & Corp. Governance Committee and Member of Quality & Compliance Committee
|Mr. Frederick D. Furry ,
Chief Financial Officer, Principal Accounting Officer and Member of Secondary Stock Option Committee
|Mr. William E. Brown ,
VP of Sales
|Mr. Daniel Merkin ,
National Sales Mang.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|